Sanfilippo syndrome: Overall review.
Barakaldo, Spain. In Pediatr Int, Jun 2015
Enzyme activity of the different enzymes in blood serum, leukocytes or fibroblasts, and mutational analysis for SGSH, NAGLU, HGSNAT or GNS genes are required to confirm diagnosis and differentiate four subtypes of MPS III.
The etiology of glomerulonephritis: roles of infection and autoimmunity.
Seattle, United States. In Kidney Int, 2014
Rapid expansion in knowledge of the microbiome and its role in health and disease, as well as systems biology approaches to glomerular disease offer the potential to develop preventive approaches to GNs that can now be treated only with immunosuppression.
Mucopolysaccharidosis III (Sanfilippo Syndrome)- disease presentation and experimental therapies.
In Pediatr Endocrinol Rev, 2014
Sanfilippo Syndrome or Mucopolysaccharidosis Ill (MPS Ill) is a group of lysosomal storage diseases resulting from a deficiency of one of four lysosomal enzymes: Type A - heparan N-sulfatase (SGSH), Type B - a-N-acetylglucosaminidase (NAGLU), Type C - acetyl CoA a-glucosaminide acetyltransferase (HGSNAT) and Type D - N-acetylglucosamine-6-sulfatase (GNS).
Pharmaceutical applications of graphene-based nanosheets.
Seoul, South Korea. In Curr Pharm Biotechnol, 2013
Graphene-based nanosheets (GNS) are atomic-thickness monolayers of hexagonally arranged, graphite-derived carbon atoms that may be composed of graphene, graphene oxide, or reduced graphene oxide.